检验医学与临床
檢驗醫學與臨床
검험의학여림상
JOURNAL OF LABORATORY MEDICINE AND CLINICAL SCIENCES
2014年
z2期
210-212
,共3页
李腾飞%肖扬%王穗源%伍群
李騰飛%肖颺%王穗源%伍群
리등비%초양%왕수원%오군
人工髋关节置换术%低分子肝素%深静脉血栓形成
人工髖關節置換術%低分子肝素%深靜脈血栓形成
인공관관절치환술%저분자간소%심정맥혈전형성
hip arthroplasty%low molecular weight heparin%deep vein thrombosis
目的:探讨人工髋关节置换(THA)术后低分子肝素(LMWH)防治深静脉血栓(DVT)形成的效果及对血液流变学的影响。方法选择2012年6月至2014年6月来该院进行人工髋关节置换术患者620例,按照数字列表法随即平均分为低分子肝素组和常规治疗组,其中常规治疗组患者术后使用常规方法预防深静脉血栓形成,低分子肝素组患者在进行常规预防方法的基础上应用低分子肝素预防深静脉血栓,每天5000 U ,比较两组患者治疗1周后深静脉血栓形成的发生率,以及术后1周血液流变学,其中包括血小板聚集率、纤维蛋白原、全血粘度及血浆粘度。结果(1)低分子肝素组患者深静脉血栓形成的发生率4.84%明显低于常规治疗组的发生率21.94%,比较差异有统计学意义(χ2=14.87,P<0.05)。(2)术后1周,低分子肝素组患者治疗后血液流变学,包括血小板聚集率、纤维蛋白原、全血粘度及血浆粘度均明显低于常规治疗组,差异有统计学意义(P<0.05)。结论人工髋关节置换术后应用低分子肝素,能使深静脉血栓形成的发生率显著降低,并且能够改善患者术后的血液流变学,安全可靠,值得临床推广。
目的:探討人工髖關節置換(THA)術後低分子肝素(LMWH)防治深靜脈血栓(DVT)形成的效果及對血液流變學的影響。方法選擇2012年6月至2014年6月來該院進行人工髖關節置換術患者620例,按照數字列錶法隨即平均分為低分子肝素組和常規治療組,其中常規治療組患者術後使用常規方法預防深靜脈血栓形成,低分子肝素組患者在進行常規預防方法的基礎上應用低分子肝素預防深靜脈血栓,每天5000 U ,比較兩組患者治療1週後深靜脈血栓形成的髮生率,以及術後1週血液流變學,其中包括血小闆聚集率、纖維蛋白原、全血粘度及血漿粘度。結果(1)低分子肝素組患者深靜脈血栓形成的髮生率4.84%明顯低于常規治療組的髮生率21.94%,比較差異有統計學意義(χ2=14.87,P<0.05)。(2)術後1週,低分子肝素組患者治療後血液流變學,包括血小闆聚集率、纖維蛋白原、全血粘度及血漿粘度均明顯低于常規治療組,差異有統計學意義(P<0.05)。結論人工髖關節置換術後應用低分子肝素,能使深靜脈血栓形成的髮生率顯著降低,併且能夠改善患者術後的血液流變學,安全可靠,值得臨床推廣。
목적:탐토인공관관절치환(THA)술후저분자간소(LMWH)방치심정맥혈전(DVT)형성적효과급대혈액류변학적영향。방법선택2012년6월지2014년6월래해원진행인공관관절치환술환자620례,안조수자렬표법수즉평균분위저분자간소조화상규치료조,기중상규치료조환자술후사용상규방법예방심정맥혈전형성,저분자간소조환자재진행상규예방방법적기출상응용저분자간소예방심정맥혈전,매천5000 U ,비교량조환자치료1주후심정맥혈전형성적발생솔,이급술후1주혈액류변학,기중포괄혈소판취집솔、섬유단백원、전혈점도급혈장점도。결과(1)저분자간소조환자심정맥혈전형성적발생솔4.84%명현저우상규치료조적발생솔21.94%,비교차이유통계학의의(χ2=14.87,P<0.05)。(2)술후1주,저분자간소조환자치료후혈액류변학,포괄혈소판취집솔、섬유단백원、전혈점도급혈장점도균명현저우상규치료조,차이유통계학의의(P<0.05)。결론인공관관절치환술후응용저분자간소,능사심정맥혈전형성적발생솔현저강저,병차능구개선환자술후적혈액류변학,안전가고,치득림상추엄。
Objective To investigate the efficacy and influence to hemorrheology of low molecular weight hep‐arin(low molecular weight heparins ,LMWH) in hip replacement surgery(total hip arthroplasty ,THA) prevention of deep vein thrombosis (deep vein thrombosis ,DVT)formation .Methods 620 cases with hip arthroplasty were select‐ed from our hospital during the period from June 2012 to June 2014 ,they were average divided into the low molecular weight heparin group and the conventional treatment group according to digital List France ,the patients of the con‐ventional treatment group were treated with conventional methods to prevent deep vein thrombosis ,the patients of the low molecular weight heparin group were given low molecular weight heparin in the prevention of deep vein thrombosis based on the conventional method ,5000 U every day ,the incidence of deep vein thrombosis 1 week after treatment of two groups were compared ,and hemorrheology include platelet aggregation ,fibrinogen ,whole blood vis‐cosity and plasma viscosity 1 week after treatment of two groups were compared .Results ① The incidence of deep vein thrombosis of the low molecular weight heparin group was 5 .00% significantly lower than 21 .67% of the con‐ventional treatment group ,the difference was statistically significant(χ2 =14 .87 ,P<0 .05);②hemorrheology inclu‐ding platelet aggregation ,fibrinogen ,whole blood viscosity and plasma viscosity 1 week after treatment of the low molecular weight heparin group significantly lower than the conventional treatment group ,the difference was statisti‐cally significant(P< 0 .05) .Conclusion low molecular weight heparin was used hip arthroplasty can significantly lower the incidence of deep vein thrombosis ,and can improve postoperative blood rheology ,safe and reliable ,was worth to spread in clinical .